查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405836

止吐药市场规模、份额和趋势分析报告：按药物类型、最终用途、地区和细分市场预测，2024-2030

Antiemetics Drugs Market Size, Share & Trends Analysis Report By Drug Type (Serotonin-receptor Antagonists, Dopamine Receptor Antagonists), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

止吐药市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球止吐药市场规模将达到112亿美元，2024年至2030年复合年增长率为5.98%。

主要企业策略倡议的增加以及引起噁心和呕吐的各种疾病的流行等因素正在推动市场需求的成长。

主要产业参与者活动的增加是加强止吐药需求的主要因素之一。市场参与企业正在采取各种倡议，例如联盟、收购、新产品发布、产品核准和业务扩张，以加强他们在止吐药市场的地位。例如，2020年5月，美国食品药物管理局核准了Helsinn Group的AKYNZEO注射液用于预防化疗引起的噁心和呕吐。因此，新产品核准的增加预计将推动未来几年的行业成长。

除了化疗和术后噁心呕吐（PONV）等关键适应症外，食物中毒和饮酒等其他情况也在预测期内推动了这些药物的需求。 NCBI 于 2021 年 11 月发表的一篇论文表明，某些非处方止吐药（例如次水杨酸铋）可以有效缓解与食物中毒相关的噁心和呕吐。

此外，2022 年 10 月发表在 Frontiers 上的一项研究发现，5-羟色胺受体拮抗Ondansetron是治疗早发性酒精成瘾(EOA) 患者酒精使用障碍的有效方法。因此，由于饮酒消费量增加和食物中毒爆发，止吐药的需求预计将会增加。

止吐药市场报告亮点

  • 从药物类型来看，到2023年，5-羟色胺受体拮抗将以29.71%的份额占据市场主导地位，这种主导地位可归因于癌症患者数量的增加和5-羟色胺受体拮抗的使用增加。
  • 从应用来看，由于越来越多的针对化疗相关噁心和呕吐的产品上市，化疗领域是市场最大的收益贡献者，到2023年将占45.70%的份额。
  • 在最终用途领域，零售药品领域占据市场主导地位，2023年收益占有率为47.91%。相比之下，其他细分市场预计在预测期内将成长最快。
  • 由于辉瑞、默克和葛兰素史克等主要参与者的存在，北美地区在 2023 年以 36.52% 的份额占据市场主导地位。同时，亚太地区预计将在预测期内出现最快的成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第四章 药品品种经营分析

  • 止吐药市场：药种波动分析
  • 血清素受体拮抗
  • 抗胆碱能药物
  • 多巴胺受体拮抗
  • 神经激肽受体拮抗
  • 其他的

第 5 章应用程式的商业分析

  • 止吐药市场：应用变化分析
  • 化疗
  • 胃肠炎
  • 术后
  • 其他的

第 6 章最终用途业务分析

  • 止吐药市场：最终用途变化分析
  • 医院和诊所
  • 零售药房
  • 其他的

第七章 区域业务分析

  • 2023 年和 2030 年按地区分類的止吐药市场占有率
  • 北美洲
    • 北美止吐药市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲止吐药市场，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太止吐药市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 拉丁美洲止吐药市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • MEA 止吐药市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 公司分类
  • 策略规划
  • 2023 年公司市场占有率分析
  • 公司简介/名单
    • Pfizer Inc.
    • Cipla Inc.
    • Merck KGaA
    • Eagle Pharmaceuticals, Inc.
    • Johnson &Johnson Services, Inc.
    • GSK plc.
    • Astellas Pharma Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Viatris Inc.
    • Baxter
Product Code: GVR-4-68040-165-9

Antiemetics Drugs Market Growth & Trends:

The global antiemetics drugs market size is expected to reach USD 11.20 billion by 2030, exhibiting a CAGR of 5.98% from 2024 to 2030, according to a new report by Grand View Research, Inc. Factors such as the increasing strategic initiatives of the key players coupled with the increasing prevalence of various diseases causing nausea and vomiting are propelling market demand forward.

The rising activity of major industry players is one of the major factors bolstering the demand for antiemetics drugs. Industry participants are undertaking various initiatives such as partnerships, acquisitions, new product launches, product approvals, and expansions to strengthen their position in the antiemetics drugs market. For instance, in May 2020, the U.S. Food and Drug Administration approved an AKYNZEO injection from the Helsinn Group for the prevention of nausea and vomiting induced by chemotherapy. Thus, increasing novel product approvals are anticipated to drive industry growth in the coming years.

In addition to key indications such as chemotherapy and postoperative nausea and vomiting (PONV), other conditions such as food poisoning and alcohol consumption are also driving the demand for these medicines over the forecast period. An article published by NCBI in November 2021 suggests that certain over-the-counter antiemetics, such as Bismuth Subsalicylate, are effective in addressing nausea and vomiting associated with food poisoning.

Moreover, a study published in Frontiers in October 2022 reported that ondansetron, a serotonin receptor antagonist, is an effective treatment for alcohol use disorder in patients with early onset alcoholism (EOA). Consequently, the demand for antiemetic medicines is expected to rise in response to increased alcohol consumption and incidents of food poisoning.

Antiemetics Drugs Market Report Highlights:

  • On the basis of drug type, the serotonin-receptor antagonists segment dominated the market at 29.71% in 2023 and this dominance can be attributed to the rising cases of cancer coupled with the increasing use of serotonin-receptor antagonist drugs.
  • Based on the application, the chemotherapy segment was the largest revenue contributor to the market with a share of 45.70% in 2023 owing to the increasing product launches targeting nausea and vomiting associated with chemotherapy.
  • In the end-use segment, the retail pharmacy segment dominated the market with a revenue share of 47.91% in 2023. In contrast, the other segment is anticipated to register the fastest growth over the forecast period.
  • The North America region dominated the market with a share of 36.52% in 2023 owing to the presence of major players like Pfizer, Merck Co & Inc, and GSK plc. On the other hand, Asia Pacific is expected to showcase the fastest growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Segment Definitions
    • 1.1.1. Drug Type Segment
    • 1.1.2. Application Segment
    • 1.1.3. End-use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations
  • 1.12. Research Assumptions

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Prevalence of Target Diseases
      • 3.2.1.2. Rising Investments by Industry Participants in R&D Activities
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Adverse Effects Associated with Anti emetics Drugs
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Drug Type Business Analysis

  • 4.1. Antiemetics Drugs Market: Drug Type Movement Analysis
  • 4.2. Serotonin-Receptor Antagonists
    • 4.2.1. Serotonin-Receptor Antagonists Market, 2018 - 2030 (USD Million)
  • 4.3. Anticholinergics
    • 4.3.1. Anticholinergics Market, 2018 - 2030 (USD Million)
  • 4.4. Dopamine Receptor Antagonists
    • 4.4.1. Dopamine Receptor Antagonists Market, 2018 - 2030 (USD Million)
  • 4.5. Neurokinin Receptor Antagonists
    • 4.5.1. Neurokinin Receptor Antagonists Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Other Drug Types Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Antiemetics Drugs Market: Application Movement Analysis
  • 5.2. Chemotherapy
    • 5.2.1. Chemotherapy Market, 2018 - 2030 (USD Million)
  • 5.3. Gastroenteritis
    • 5.3.1. Gastroenteritis Market, 2018 - 2030 (USD Million)
  • 5.4. Post-Operative Surgery
    • 5.4.1. Post Operative Surgery Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Antiemetics Drugs Market: End-use Movement Analysis
  • 6.2. Hospital & Clinics
    • 6.2.1. Hospital & Clinics Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Other End-use Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Antiemetics Drugs Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. North America Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. U.S. Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Canada Antiemetics Drugs Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. UK Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Germany Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. France Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Italy Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Spain Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Denmark Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Sweden Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Norway Antiemetics Drugs Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Japan Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. China Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. India Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Australia Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Thailand Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. South Korea Antiemetics Drugs Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Brazil Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Mexico Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Argentina Antiemetics Drugs Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. South Africa Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Saudi Arabia Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. UAE Antiemetics Drugs Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Kuwait Antiemetics Drugs Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Pfizer Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Cipla Inc.
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Merck KGaA
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Eagle Pharmaceuticals, Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Johnson & Johnson Services, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. GSK plc.
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Astellas Pharma Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. GLENMARK PHARMACEUTICALS LTD.
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Viatris Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Baxter
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 4 Global Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 Global Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Antiemetics Drugs Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 North America Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 9 North America Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 21 UK Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 22 UK Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 UK Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 24 Germany Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 25 Germany Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 27 France Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 28 France Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 Spain Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 31 Spain Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Spain Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39 Norway Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 40 Norway Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Norway Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 49 China Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 50 China Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 China Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 Japan Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Japan Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55 India Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 56 India Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 59 South Korea Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 Australia Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Latin America Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million),
  • Table 78 Argentina Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 80 MEA Antiemetics Drugs Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 MEA Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 82 MEA Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 83 MEA Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 UAE Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 88 UAE Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 UAE Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million),
  • Table 91 Saudi Arabia Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Antiemetics Drugs Market, By Drug Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Antiemetics Drugs Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Antiemetics Drugs Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Antiemetics drugs market segmentation
  • Fig. 8 Market snapshot, 2023
  • Fig. 9 Market Trends & outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 Global antiemetics drugs market: Drug type outlook and key takeaways
  • Fig. 15 Global antiemetics drugs market: Drug type movement analysis
  • Fig. 16 Global antiemetics drugs market, for serotonin-receptor antagonists, 2018 - 2030 (USD Million)
  • Fig. 17 Global antiemetics drugs market, for anticholinergics, 2018 - 2030 (USD Million)
  • Fig. 18 Global antiemetics drugs market, for dopamine receptor antagonists, 2018 - 2030 (USD Million)
  • Fig. 19 Global antiemetics drugs market, for neurokinin receptor antagonists, 2018 - 2030 (USD Million)
  • Fig. 20 Global antiemetics drugs market, for other drug types, 2018 - 2030 (USD Million)
  • Fig. 21 Global antiemetics drugs market: Application outlook and key takeaways
  • Fig. 22 Global antiemetics drugs market: Application movement analysis
  • Fig. 23 Global antiemetics drugs market, for chemotherapy, 2018 - 2030 (USD Million)
  • Fig. 24 Global antiemetics drugs market, for gastroenteritis, 2018 - 2030 (USD Million)
  • Fig. 25 Global antiemetics drugs market, for post-operative surgery, 2018 - 2030 (USD Million)
  • Fig. 26 Global antiemetics drugs market, for others, 2018 - 2030 (USD Million)
  • Fig. 27 Global antiemetics drugs market: End-use outlook and key takeaways
  • Fig. 28 Global antiemetics drugs market: End-use movement analysis
  • Fig. 29 Global antiemetics drugs market, for hospital & clinics, 2018 - 2030 (USD Million)
  • Fig. 30 Global antiemetics drugs market, for retail pharmacy, 2018 - 2030 (USD Million)
  • Fig. 31 Global antiemetics drugs market, for others, 2018 - 2030 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 Regional outlook, 2023 & 2030
  • Fig. 34 Global antiemetics drugs market: Region movement analysis
  • Fig. 35 North America antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 36 US antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 37 Canada antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 40 UK antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 41 France antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 48 Japan antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 49 China antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 50 India antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 61 UAE antiemetics drugs market, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait antiemetics drugs market, 2018 - 2030 (USD Million)